News ID: 314262
Published: 0720 GMT June 26, 2021

Iran starts manufacturing Russian COVID vaccine

Iran starts manufacturing Russian COVID vaccine

An Iranian pharmaceutical company has started manufacturing Russia’s flagship coronavirus vaccine as a top official defends protectionism applied to government’s vaccine supply policy which barred foreign manufacturers from launching clinical trials in Iran.

Vials of Sputnik V vaccine produced in Iran were unveiled on Saturday in a ceremony held in the headquarters of Actover Co., a drug company whose manufacturing sites are located some 30 kilometers to the west of the capital Tehran in Alborz Province, Press TV reported.

Iran’s Health Minister Saeid Namaki and the country’sAambassador to Russia Kazem Jalali were present in the ceremony also attended by representatives from Russia’s government and the private sector.

Actover will produce two million doses of Sputnik V per month, according to a company official who said that the firm had obtained all certificates needed to produce the vaccine inside Iran, including those required by Russia’s Gamaleya Institute.

Iran reached an agreement with Russia late last year to take delivery of tens of millions of Sputnik V vaccines to use them in its national inoculation program against the coronavirus.

To further boost the supplies, Iranian health ministry authorities also signed deals with Gamaleya and government agencies in Russia to launch local manufacturing of the vaccine by two Iranian pharmaceutical companies.

Iran has scaled up production for its home-made vaccines while also using supplies from China and COVAX, a project sponsored by the World Health Organization.

During the unveiling ceremony on Saturday health minister Saeid Namaki defended the government’s decision to avoid human trials of vaccines developed by major Western manufacturers.

Namaki said that the protectionist approach was adopted to protect the Iranian population against any risks associated with vaccine development process.

He said only vaccine developers from Cuba and Russia were allowed to launch the so-called phase III vaccine trials in Iran because they had shared their technology and allowed its use for joint manufacturing schemes inside Iran.


Security Key:
Captcha refresh
Page Generated in 0/1052 sec